Monday, November 28, 2016

In global first, Teva signs deal to market medical marijuana inhaler

By Shoshanna Solomon at Times Of Israel

 

 "The company has completed clinical trials, which demonstrated the inhaler’s precision and compliance with pharmaceutical standards for the delivery of inhaled cannabis." ...

 ... "To date Syqe has raised $33 million, including $20 million from Philip Morris International, according to data provided by the company."

No comments:

Post a Comment